Clinical Trials Browser

Phase 2 × VEXAS syndrome × Clear all

NCT06782373 2026-03-12

A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)

Phase 2 Recruiting

MyeloidOther hematologic neoplasm

VEXAS syndrome, Myelodysplastic Syndromes, Hematologic Neoplasms